mechlorethamine has been researched along with dronabinol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kluin-Neleman, JC; Maes, RA; Meuwissen, OJ; Neleman, FA | 1 |
| Kaplan, NC | 1 |
1 review(s) available for mechlorethamine and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mechlorethamine and dronabinol
| Article | Year |
|---|---|
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Male; Mechlorethamine; Middle Aged; Placebos; Prednisone; Procarbazine; Vincristine | 1979 |
1 other study(ies) available for mechlorethamine and dronabinol
| Article | Year |
|---|---|
Dichloroethyl carbamoyl ester of delta-9-tetrahydrocannabinol. Chemical synthesis and biological testing and evaluation as a potentially site-specific anti-tumor agent.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Dronabinol; Drug Evaluation, Preclinical; Drug Synergism; Mechlorethamine; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats | 1984 |